Related Experiment Video
Updated: Jan 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Clinical progress note: Invasive meningococcal disease
Alaina Shine1, Erin Chung2,3,4
1Department of Pediatrics, Division of Hospital Medicine, University of Washington, Seattle, Washington, USA.
Abstract:
Invasive meningococcal disease due to Neisseria meningitidis in the United States has decreased since the late 1990s, leading to fewer practicing clinicians with first-hand experience in diagnosing and managing of the disease. However, since 2021, cases have increased, creating an urgency for clinicians to familiarize themselves with the signs and sequelae of severe invasive meningococcal disease and stay up to date with current vaccine recommendations. This review summarizes recent literature and guidance for clinicians on the prevention, early recognition, and management of this vaccine-preventable disease.
Insights
Invasive meningococcal disease cases are rising in the US. Clinicians need updated knowledge on recognizing, managing, and preventing this serious Neisseria meningitidis infection, emphasizing current vaccine strategies.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Invasive meningococcal disease (IMD) caused by Neisseria meningitidis has seen a decline in the US since the late 1990s.
- This decline has resulted in reduced clinical experience with IMD diagnosis and management.
- Recent increases in IMD cases since 2021 necessitate renewed clinician focus.
Purpose of the Study:
- To provide clinicians with updated information on invasive meningococcal disease.
- To review current literature and guidance for prevention, recognition, and management.
- To address the urgency created by the recent rise in IMD cases.
Main Methods:
- This is a review article.
- It summarizes recent literature and clinical guidance.
- Focuses on prevention, early recognition, and management strategies.
Main Results:
- Invasive meningococcal disease (Neisseria meningitidis) has seen an increase in the US since 2021.
- Clinicians require updated knowledge on signs, sequelae, and management.
- Current vaccine recommendations are crucial for prevention.
Conclusions:
- Clinicians must re-familiarize themselves with invasive meningococcal disease due to rising cases.
- Staying updated on Neisseria meningitidis prevention, recognition, and management is critical.
- Adherence to current vaccine recommendations is essential for controlling this vaccine-preventable disease.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis IV: Nursing Management
Stages of Infection

